Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Explore tax-efficient passive income sources in retirement and how different streams affect taxes, ensuring you optimize withdrawals and eligibility.
24,018 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Broadcom's AI outlook miss triggered a pronounced one-day pullback, signaling investor caution around AI-driven growt...
In May, Grail stock surged on optimism about FDA approval timing and potential reimbursement for the Galleri MCED tes...
Three months after the Hormuz disruption, oil prices remain subdued. Record U.S. exports, a slowdown in Chinese deman...
A major AI and cloud deal is flanking SpaceX's IPO, potentially nudging investor sentiment. This article breaks down ...
A surprise board appointment paired with a sizable stock purchase has investors buzzing. Learn what this insider move...
Elon Musk has floated a colossal Terafab project aimed at dramatically scaling U.S. chip production from a single pla...
Artificial intelligence is delivering measurable efficiency in health care, but the race now focuses on who benefits—...
June brought a high-stakes move in AI infrastructure funding. Super Micro Computer announced a $7B equity financing p...
Mind tech (mind) 2027 is shaping a new era for investors who seek durable growth in neurotech and digital mental heal...
Osasuna is under fire after reports it used a Kalshi contract to hedge the financial hit of relegation. The club deni...
Retail traders are driving a surge in futures activity as CME Group reports record May volume. This piece explains ho...